Franklin Genomic Advancements ETF (HELX)
BATS: HELX · Real-Time Price · USD
27.98
-0.02 (-0.08%)
Mar 11, 2025, 4:00 PM EST - Market closed
HELX Holdings List
As of Mar 12, 2025
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 5.30% |
| 2 | KRYS | Krystal Biotech, Inc. | 5.11% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 4.89% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 4.14% |
| 5 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 3.77% |
| 6 | MEDP | Medpace Holdings, Inc. | 3.64% |
| 7 | LLY | Eli Lilly and Company | 3.38% |
| 8 | TMO | Thermo Fisher Scientific Inc. | 3.37% |
| 9 | AZN | AstraZeneca PLC | 2.93% |
| 10 | CTVA | Corteva, Inc. | 2.65% |
| 11 | BNTX | BioNTech SE | 2.62% |
| 12 | UTHR | United Therapeutics Corporation | 2.49% |
| 13 | INSM | Insmed Incorporated | 2.41% |
| 14 | ETR: SRT3 | Sartorius Aktiengesellschaft | 2.38% |
| 15 | SRPT | Sarepta Therapeutics, Inc. | 2.36% |
| 16 | DHR | Danaher Corporation | 2.19% |
| 17 | TWST | Twist Bioscience Corporation | 2.08% |
| 18 | RVTY | Revvity, Inc. | 2.08% |
| 19 | RARE | Ultragenyx Pharmaceutical Inc. | 1.99% |
| 20 | GH | Guardant Health, Inc. | 1.95% |
| 21 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.94% |
| 22 | EXAS | Exact Sciences Corporation | 1.83% |
| 23 | CDNS | Cadence Design Systems, Inc. | 1.72% |
| 24 | LGND | Ligand Pharmaceuticals Incorporated | 1.48% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 1.47% |
| 26 | CRL | Charles River Laboratories International, Inc. | 1.44% |
| 27 | QGEN | Qiagen N.V. | 1.44% |
| 28 | RGEN | Repligen Corporation | 1.40% |
| 29 | SWX: LONN | Lonza Group AG | 1.36% |
| 30 | A | Agilent Technologies, Inc. | 1.33% |
| 31 | LH | Labcorp Holdings Inc. | 1.24% |
| 32 | BMRN | BioMarin Pharmaceutical Inc. | 1.23% |
| 33 | BEAM | Beam Therapeutics Inc. | 1.07% |
| 34 | ADPT | Adaptive Biotechnologies Corporation | 1.05% |
| 35 | IQV | IQVIA Holdings Inc. | 1.02% |
| 36 | TEM | Tempus AI, Inc. | 0.99% |
| 37 | NBIX | Neurocrine Biosciences, Inc. | 0.98% |
| 38 | EBR: ARGX | argenx SE | 0.97% |
| 39 | AZTA | Azenta, Inc. | 0.92% |
| 40 | RXRX | Recursion Pharmaceuticals, Inc. | 0.90% |
| 41 | BRKR | Bruker Corporation | 0.90% |
| 42 | DOCS | Doximity, Inc. | 0.89% |
| 43 | TECH | Bio-Techne Corporation | 0.87% |
| 44 | IONS | Ionis Pharmaceuticals, Inc. | 0.80% |
| 45 | VCYT | Veracyte, Inc. | 0.79% |
| 46 | BIO | Bio-Rad Laboratories, Inc. | 0.64% |
| 47 | n/a | Us Dollar | 0.62% |
| 48 | GRAL | GRAIL, Inc. | 0.62% |
| 49 | DVAX | Dynavax Technologies Corporation | 0.60% |
| 50 | ARE | Alexandria Real Estate Equities, Inc. | 0.56% |
| 51 | ICLR | ICON Public Limited Company | 0.48% |
| 52 | SDGR | Schrödinger, Inc. | 0.47% |
| 53 | WGS | GeneDx Holdings Corp. | 0.44% |
| 54 | BMY | Bristol-Myers Squibb Company | 0.41% |
| 55 | AVTR | Avantor, Inc. | 0.39% |
| 56 | VYGR | Voyager Therapeutics, Inc. | 0.39% |
| 57 | PTCT | PTC Therapeutics, Inc. | 0.28% |
| 58 | CRSP | CRISPR Therapeutics AG | 0.28% |
| 59 | CPH: BAVA | Bavarian Nordic A/S | 0.28% |
| 60 | WVE | Wave Life Sciences Ltd. | 0.26% |
| 61 | CPRX | Catalyst Pharmaceuticals, Inc. | 0.24% |
| 62 | TVTX | Travere Therapeutics, Inc. | 0.23% |
| 63 | CDNA | CareDx, Inc | 0.22% |
| 64 | MRNA | Moderna, Inc. | 0.21% |
| 65 | NGNE | Neurogene Inc. | 0.16% |
| 66 | RCKT | Rocket Pharmaceuticals, Inc. | 0.13% |
| 67 | NTLA | Intellia Therapeutics, Inc. | 0.10% |
| 68 | SLP | Simulations Plus, Inc. | 0.10% |
| 69 | ETR: EVT | Evotec SE | 0.07% |
| 70 | FDMT | 4D Molecular Therapeutics, Inc. | 0.06% |
| 71 | n/a | Danish Krone | 0.00% |
| 72 | n/a | Euro Currency | 0.00% |
| 73 | n/a | Omniab | 0.00% |
| 74 | n/a | Omniab | 0.00% |
| 75 | n/a | South Korean Won | 0.00% |
As of Mar 12, 2025